
A recent multi-centered study explored the use of vasopressin as a second-line treatment for septic shock. The study analyzed data from 302 patients, comparing outcomes based on the timing of vasopressin initiation and norepinephrine (NE) dose. Propensity-score matching identified 73 patients in each group. Results showed no significant difference in vasopressor duration between groups but a lower fluid balance at 72 hours when vasopressin was initiated at lower NE doses. Notably, earlier vasopressin initiation (within 4 hours) correlated with a shorter time to shock resolution. The study provides insights into septic shock management.
Like
Save
Share